Charles Schwab Investment Management Inc Xeris Biopharma Holdings, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 402,872 shares of XERS stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
402,872
Previous 403,361
0.12%
Holding current value
$1.44 Million
Previous $1.15 Million
18.8%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding XERS
# of Institutions
145Shares Held
60.7MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$27.8 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$18.3 Million62.59% of portfolio
-
Center Book Partners LP Greenwich, CT3.48MShares$12.5 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$11.9 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $487M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...